Artelo Biosciences (ARTL) Stock Chart & Stock Price History $0.95 -0.02 (-1.67%) Closing price 04/17/2025 03:53 PM EasternExtended Trading$0.88 -0.07 (-7.53%) As of 04/17/2025 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Artelo Biosciences Stock Price Performance 5 Day Performance-7.40%1 Month Performance-3.56%3 Month Performance-18.76%6 Month Performance-17.06%Year-To-Date Performance-10.02%1 Year Performance-27.47% Receive ARTL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Artelo Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address ARTL Stock Chart for Sunday, April, 20, 2025 ARTL Chart by TradingView Artelo Biosciences Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2025$0.95$0.95$0.96$0.88125,464 shs$3.13 million04/17/2025$0.97$0.95-1.67%$0.96$0.88125,464 shs$3.13 million04/16/2025$1.03$0.97-5.83%$0.98$0.90230,664 shs$3.18 million04/15/2025$0.97$1.03+6.25%$1.03$0.89479,750 shs$3.38 million04/14/2025$0.85$0.97+14.18%$1.40$0.8522.85 million shs$3.18 million04/11/2025$0.82$0.85+3.27%$0.89$0.8250,165 shs$2.79 million04/10/2025$0.92$0.82-10.63%$0.91$0.823,131 shs$2.70 million04/09/2025$0.86$0.92+7.46%$0.93$0.8220,278 shs$3.02 million04/09/2025$0.86$0.92+7.46%$0.93$0.8220,278 shs$3.02 million04/08/2025$0.88$0.86-2.73%$0.98$0.8631,014 shs$2.81 million Get the Latest News and Ratings for ARTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Artelo Biosciences and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025$0.88$0.86-2.73%$0.98$0.8631,014 shs$2.81 million04/07/2025$0.92$0.88-4.10%$0.91$0.8516,763 shs$2.89 million04/04/2025$0.90$0.92+1.84%$0.92$0.8547,011 shs$3.01 million04/03/2025$0.88$0.90+1.88%$0.92$0.8521,179 shs$2.96 million04/02/2025$0.86$0.88+2.83%$0.90$0.884,765 shs$2.90 million04/01/2025$0.88$0.86-1.70%$0.88$0.868,186 shs$2.82 million03/31/2025$0.94$0.88-6.91%$0.94$0.8616,282 shs$2.87 million03/28/2025$0.97$0.94-2.59%$0.96$0.948,953 shs$3.08 million03/27/2025$0.96$0.97+0.94%$0.97$0.959,413 shs$3.17 million03/26/2025$0.97$0.96-1.55%$0.97$0.964,010 shs$3.14 million03/25/2025$0.98$0.97-1.05%$1.01$0.9713,347 shs$3.19 million03/24/2025$1.04$0.98-5.63%$1.03$0.9815,229 shs$3.22 million03/21/2025$0.99$1.04+5.16%$1.04$0.9621,608 shs$3.41 million03/20/2025$0.95$0.99+4.11%$0.99$0.9317,457 shs$3.25 million03/19/2025$0.92$0.95+3.15%$0.96$0.9115,747 shs$3.12 million Related Companies Bright Green Stock Price Chart Cellectar Biosciences Stock Price Chart GlycoMimetics Stock Price Chart Spruce Biosciences Stock Price Chart Moleculin Biotech Stock Price Chart Leap Therapeutics Stock Price Chart Marker Therapeutics Stock Price Chart NextCure Stock Price Chart ABVC BioPharma Stock Price Chart PHAXIAM Therapeutics Stock Price Chart Receive ARTL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Artelo Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARTL) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
